Afsheen Hayat Siddiqui

Afsheen Siddiqui practices at Johns Hopkins Howard County Medical Center in Columbia, Maryland, part of Johns Hopkins Health System.

Afsheen Siddiqui's NPI, 1205366911, was assigned on June 14, 2017. Afsheen Siddiqui holds Maryland license D0088969.

Afsheen Siddiqui's primary practice is Johns Hopkins Howard County Medical Center, at 5755 Cedar Lane, Columbia, MD 21044 in Howard County. The practice phone is (410) 740-7890.

Afsheen Siddiqui's primary practice is Johns Hopkins Howard County Medical Center in Columbia, Maryland, part of Johns Hopkins Health System. Afsheen Siddiqui is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins Community Physicians. Dmand AI also links Afsheen Siddiqui to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Afsheen Siddiqui practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Afsheen Siddiqui's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Afsheen Siddiqui's licenses on file in 2 states: Maryland and District of Columbia.

CMS data shows 871 Medicare services from Afsheen Siddiqui across 5 procedure codes in 2024, for 457 Medicare patients. Medicare paid $79,100 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 457 Medicare patients who saw Afsheen Siddiqui in 2024. The largest group is 75 to 84, with 172 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Afsheen Siddiqui's median patient age at 78, with 58% women.

In 2024, Afsheen Siddiqui wrote 266 Medicare Part D claims for 117 patients. 88% of them were for generic drugs. CMS names the drug for 50 of them, across 3 drugs with 11 or more claims each, at $391 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Afsheen Siddiqui for performance year 2024, reported as part of a group. Afsheen Siddiqui accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Afsheen Siddiqui, published from 2017 to 2023. Afsheen Siddiqui's most frequent co-authors are Jason M. Elinoff, MD and Nargues Amir Weir, MD.

CMS Open Payments shows 16 general payments to Afsheen Siddiqui from 9 drug and device companies from 2017 to 2020. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $144.